Coastlinebio
Oakland, US · 1 known investors
Coastline Bio is a biopharmaceutical company developing novel medicines for immunological skin diseases, with an initial focus on atopic dermatitis. The company is developing a first-in-class monoclonal antibody targeting disease pathways in skin conditions.
BiotechHealthtechMedical Devices